CPT code 88167 covers a two-step cytopathology workflow in which a lab analyst performs a manual review of a cervical or vaginal cytology slide and then rescreens the same slide using computer-assisted cell selection and review, reporting results with the Bethesda System. This code reflects the integration of automated tools into conventional cytology practice, improving targeted review while maintaining supervised technical performance. Nationally, the code matters as laboratories adopt computer-assisted technologies that can affect workflow, documentation, and payer coverage policies.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical and billing context, common modifiers used with lab services, typical sites of service, and what to expect in payer coverage approaches. The publication also outlines benchmarks and policy considerations relevant to laboratories and billing professionals, and summarizes clinical reporting conventions tied to the Bethesda System.

The content is intended for laboratory managers, coding and billing staff, and policy analysts who need a clear national view of how 88167 fits into cytology service delivery, documentation, and payer interactions. Data not available in the input is noted where applicable.